Florida International University

FIU Digital Commons
FIU Electronic Theses and Dissertations

University Graduate School

11-12-2020

Sensor Approach for Brain Pathophysiology of Freezing of Gait in
Parkinson's Disease Patients
Juan Sebastian Marquez Jaramillo
jmarq056@fiu.edu

Follow this and additional works at: https://digitalcommons.fiu.edu/etd
Part of the Electrical and Computer Engineering Commons

Recommended Citation
Marquez Jaramillo, Juan Sebastian, "Sensor Approach for Brain Pathophysiology of Freezing of Gait in
Parkinson's Disease Patients" (2020). FIU Electronic Theses and Dissertations. 4560.
https://digitalcommons.fiu.edu/etd/4560

This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It
has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU
Digital Commons. For more information, please contact dcc@fiu.edu.

FLORIDA INTERNATIONAL UNIVERSITY
Miami, Florida

SENSOR APPROACH FOR BRAIN PATHOPHYSIOLOGY OF FREEZING OF
GAIT IN PARKINSON’S DISEASE PATIENTS

A dissertation submitted in partial fulfillment of
the requirements for the degree of
DOCTOR OF PHILOSOPHY
in
ELECTRICAL AND COMPUTER ENGINEERING
by
Juan Sebastian Marquez Jaramillo

2020

To: Dean John L. Volakis
College of Engineering and Computing
This dissertation, written by Juan Sebastian Marquez Jaramillo, and entitled
Sensor Approach for Brain Pathophysiology of Freezing of Gait in Parkinson's Disease
Patients, having been approved in respect to style and intellectual content, is referred
to you for judgment.
We have read this dissertation and recommend that it be approved.
_______________________________________
Elias Alwan
_______________________________________
Armando Barreto
_______________________________________
Wei-Chiang Lin
_______________________________________
Corneliu C Luca
_______________________________________
Ou Bai, Major Professor
Date of Defense: November 12, 2020
The dissertation of Juan Sebastian Marquez Jaramillo is approved.
_______________________________________
Dean John L. Volakis
College of Engineering and Computing
_______________________________________
Andrés G. Gil
Vice President for Research and Economic Development
and Dean of the University Graduate School

Florida International University, 2020

ii

© Copyright 2020 by Juan Sebastian Marquez Jaramillo
All rights reserved.

iii

DEDICATION
To my ever-loving and supporting family

iv

ACKNOWLEDGMENTS
First, I would like to thank my advisor, Dr. Ou Bai, for his support, accessibility, and drive
to innovate. Having him as a researcher model has inspired me to be a lifelong learner and to
examine problems as opportunities for novelty.
I also thank the members of my committee, Dr. Alwan, Dr. Barreto, Dr. Lin, and Dr. Luca, for
taking the time to evaluate and comment on this dissertation. Special thanks to Dr. Luca for
introducing me to the field of Parkinson's Disease research.
A cordial acknowledgment to my lab colleagues at the Human Cyber-Physical Systems lab:
Roozbeh, Masudur, Rod, Tushar, Tong, Robin, Connie, and Kaida.
This research was supported by the Graduate assistantship from the Department of Electrical
and Computer Engineering at Florida International University and the National Science Foundation
(CNS-1552163).

v

ABSTRACT OF THE DISSERTATION
SENSOR APPROACH FOR BRAIN PATHOPHYSIOLOGY OF FREEZING OF
GAIT IN PARKINSON’S DISEASE PATIENTS
by
Juan Sebastian Marquez Jaramillo
Florida International University, 2020
Miami, Florida
Professor Ou Bai, Major Professor
Parkinson's Disease (PD) affects over 1% of the population over 60 years of age and is
expected to reach 1 million in the USA by the year 2020, growing by 60 thousand each
year. It is well understood that PD is characterized by dopaminergic loss, leading to
decreased executive function causing motor symptoms such as tremors, bradykinesia,
dyskinesia, and freezing of gait (FoG) as well as non-motor symptoms such as loss of smell,
depression, and sleep abnormalities. A PD diagnosis is difficult to make since there is no
worldwide approved test and difficult to manage since its manifestations are widely
heterogeneous among subjects. Thus, understanding the patient subsets and the neural
biomarkers that set them apart will lead to improved personalized care. To explore the
physiological alternations caused by PD on neurological pathways and their effect on
motor control, it is necessary to detect the neural activity and its dissociation with healthy
physiological function. To this effect, this study presents a custom ultra-wearable sensor
solution, consisting of electroencephalograph, electromyograph, ground reaction force, and
symptom measurement sensors for the exploration of neural biomarkers during active gait
paradigms. Additionally, this study employed novel de-noising techniques for dealing with
vi

the motion artefacts associated with active gait electroencephalography (EEG) recordings
and compared time-frequency features between a group of PD with FoG and a group of
age-matched controls and found significant differences between several EEG frequency
bands during start and end of normal walking (with a p<0.05).
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CHAPTER 1 INTRODUCTION

1.1

Parkinson’s Disease and Freezing of Gait

As the second most common neurodegenerative disorder, Parkinson's Disease (PD)
affects over 1% of the population over 60 years of age and is expected to reach 1 million
in the USA by the year 2020, growing by 60 thousand each year [1], [2]. It is well
understood that PD is characterized by dopaminergic loss [3], leading to decreased
executive function causing motor symptoms such as tremors, bradykinesia, dyskinesia, and
freezing of gait (FoG) as well as non-motor symptoms such as loss of smell, depression,
and sleep abnormalities [4]. Although tremors are one of the most common symptoms,
persons with PD (PwP) list falls and gait abnormalities as the most debilitating symptoms,
indicating the urgency of focus and leading to the emphasis of this work [5], [6]. FoG
affects over half the population with advanced Parkinson's Disease [7]. This highly
disabling symptom is defined as “brief episodes of inability to step or by extremely short
steps that typically occur on initiating gait or on turning while walking”[8]. FoG is often
responsible for falls within PD and is highly associated with recurrent falls[9], [10].
Although there are pharmacological, therapeutic, and surgical treatments to alleviate PDFoG, evidence to support their effects is inconclusive[11]. As the leading cause of disabling
falls, understanding what causes FoG holds a tremendous public health impact. To date, no
accepted model completely explains FoG as this symptom is complex, rare to capture under
observation, and varies during manifestation.
A PD diagnosis is difficult to make since there is no worldwide approved test and
difficult to manage since its manifestations are widely heterogeneous among persons with
Parkinson's Disease (PwP) [12]–[14]. PD patients often develop medication tolerance and
1

for some, the medication is not at all effective. In the case of unmanageable symptoms,
specialists in movement disorders may choose to perform neurosurgery, which involves
the insertion of electrical stimulators deep in the brain that may cost as much as $100K[15].
This procedure, however, does not guarantee symptom improvement, as even the location
for stimulation depends on what symptom is targeted[16], [17]. Better care strategies that
consider the differences between patients are needed. Understanding the PD patient subsets
and the neural biomarkers that sets them apart will lead to successful personalized care.
To explore the physiological alternations caused by PD on neurological pathways and
their effect on motor control, it is necessary to detect the neural activity and its dissociation
with healthy physiological function. Additionally, the branching systems which are
affected by the pathology must also be studied. To this effect, great effort has been placed
in the understanding of movement-related cortical potentials (MRCPs), a type of neural
activity that occurs before voluntary movement, mostly during upper limb tasks. The
restrains on MRCPs associated with upper extremities have been partly shaped by the
instrument limitations, requiring the avoidance of movement artefacts and the
complications brought by multisensory recordings. Furthermore, the challenge of
movement artefacts from the recording setups as well as the noise that comes from active
gait, affect experiment feasibility and reliability, deter previous efforts to understand the
connections between neural conditions and active gait. Hence, there is still a knowledge
gap for the relationship between cortical modulations and active gait showing altered
pathophysiology in PD patients who exhibit FoG.

2

1.2

Relevant Works

FoG can be provoked by different triggers including turning, multi-tasking, and
emotional states [18]. Due to the nature of FoG and its multi-systemic neural impairments,
disturbances to individual brain regions are difficult to isolate. This further complicates the
understanding of this symptom, which sometimes causes medication intervention and
treatment to be unfocused, non-specific, and unsuccessful. To this effect, many research
groups have used a variety of methods and approaches to understand the
pathophysiological mechanisms behind FoG. Among the most notable approaches are
behavioral and clinical measures ranging from gait and posture[6], [19]–[24], upper limb
biomechanics[25], jaw displacement[26], saccade latency, velocity, and gain[27], audiospinal reflex[28], handwriting measures[29], foot pedal measures[30], speech[31],
electromyography (EMG) [32], [33], and even rapid eye movement frequency[34].
However, to explore the physiological changes specifically related to FoG in neurological
pathways and their effect on motor control, it is necessary to detect efficacious neural
biomarkers that may differentiate PD from healthy controls and PD subtypes from one
another. To accomplish this, the research tools that have been applied include functional
near-infrared spectroscopy [35], EEG [24], [36]–[39], deep brain electrode-based
recordings[37], [40]–[44], and various neuroimaging tools such as functional magnetic
resonance imaging (MRI) volumetric MRI, or diffusion MRI [45]–[48], and positron
emission tomography [46], [47]. It is well known that each of these methods has a benefit
over the other, for example, the spatial vs temporal resolution advantage held by fMRI over
EEG, or the non-invasive vs surgical advantage of EEG over deep brain electrode-based
recordings.

3

Recent studies that focus on clarifying the mechanisms behind FoG rely on functional
MRI, which are restricted to motor imaging [45], [49], or EEG and are limited to minimal
executive motor control, such as finger flexion [50]. To the author’s knowledge, only one
other study has attempted to examine the mechanisms underlying FoG for PwP using EEG
during active gait [51]. This study found that a reduction in the early slope of the MRCP
was consistent with stride length reduction, and based on their findings, they further state
that PwP will exhibit electrical differences both in the preparatory and executive portions
of gait [52]. However, the group also goes on to discuss its experimental flaws, including
the short gait cycle duration, composed of only 3 steps, which in turn led to the inability to
guarantee voluntary movement and automaticity after initiation. Similar studies, focusing
on PwP and FoG, have focused on evaluating the power spectral densities calculated from
EEG [53], [54], or corticomuscular coherence in non-FoG PwP [55]. This work will aim
to combine whole-body sensing, composed of wearable EEG, ground reaction force (GRF),
EMG, and behavioral outcomes for FoG pathophysiology exploration.

1.3

Motivation

The proposed study has only recently been made possible, thanks to advances in
interconnectivity allowing for synchronous recordings of the modalities mentioned above.
The miniaturization of integrated circuits, the multi-sensory fusion to remove motion
artefacts, and both the cost and battery efficiency have permitted for research to be taken
outside of the lab and into more real settings, allowing for longer recordings, more natural
experimental paradigms, and more applicable conclusions[56]–[61]. Although the systems
have been proven in other applications, we expect to face difficulties in data collection,
processing, and analysis. An active gait neural recording often consists of multiple
4

repetitions of the same task, usually ranging from forty to upwards of three hundred trials
of repeated events. As the proposed study will focus on PD, a cognitive and motor
impairing disease, new hardware and software platform for accurate measurement of
cortical activity associated with active gait is proposed to overcome signal corrupting
motion artefacts. Once data is rid of motion artefacts and been successfully processed, data
analysis will institute the continuation of the work, as interpretation will rely heavily on a
thorough understanding of the neurophysiology and proposed underlying mechanisms
behind FoG biomarkers. Success will thus be contingent on finding biomarkers that
differentiate PwP with FoG and healthy control. The proposed work will be divided into
the following:
Task (1): Develop and test an ultra-wearable, whole-body suite capable of sensing
neural features associated with supplementary motor area activity during active gait.
Task (2): Ensure related cortical potentials recorded using the sensor suite are rid of
stationary and non-stationary artefacts.
Task (3): Clinical feasibility of the ultra-wearable neural exploration suite during active
gait paradigms
Question 1: Whether the amplitudes of Bereitshaftspotentials (BP), an early
component of MRCP, or other neural features are affected in PD patients while performing
preparatory active gait compared with healthy controls.
Questions 2: Whether MRCP is altered following Levodopa administration in PD
patients with and without FoG during active gait compared with healthy controls.

5

The intellectual merits of this work will rise from the implementation of smart sensing
technologies in the application of neurophysiology exploration. This work will explore
novel synchronous wearable recordings of non-invasive top-down sensors for whole-body
event analysis. The analysis and multisensory implementation, consisting of electrical
potentials

from

scalp

electrodes

in

electroencephalography,

skin-surface

electromyography, lower and upper limb features related to symptoms and locomotion will
(1) yield motion artefact attenuation from multisensory synchronization of wearable
sensors capable of delivering reliable and valid data; (2) allow for a better understanding
of FoG pathophysiology and its effects on neural pathways and lower limbs during active
gait, and (3) expand pathophysiology research bounds by the validation of multisensory
active gait paradigms.

6

CHAPTER 2 NEURAL CORRELATES OF FREEZING OF GAIT IN PD: AN
ELECTROPHYSIOLOGY REVIEW

2.1

Pathophysiology Mechanisms Underlying FoG

Locomotion is a complex process that involves both automatic, emotional, and
volitional control [62]–[64]. In non-automatic gait, the initiation command is generated at
the cerebral cortex and is executed by the thalamocortical, corticobulbar, and spinal
projections networks [62]. Automatic rhythmicity, posture preparations, and adjustments
during locomotion are regulated by the brainstem and spinal cord after gait is volitionally
initiated. Meanwhile, the cerebellum simultaneously takes in the sensory feedback from
the spinal cord and feed-forward information from the cortex to regulate predictive control
[65]. In PD, multilevel network failure may ultimately lead to FoG events. However, the
neural complexity leads to uncertainty in identifying and isolating specific neural
impairments that result in FoG. To explain the pathophysiology, five non-exclusive
mechanisms have been suggested regarding the physiological alterations leading to FoG
[8], [18].

7

Figure 1. Five FoG Neural Mechanisms. H1. Abnormal control outputs from central pattern
generators. The supraspinal locomotor network (SLN) is composed of the premotor cortex (PMC),
supplementary motor area (SMA), parietal cortex, basal ganglia (BG), subthalamic nucleus (STN),
mesencephalic locomotor region (MLR), and cerebellum. ↓ In normal function, the SLN network sends
cues for turning, stopping, obstacle maneuvering, and new locomotion goals. X In PD, FoG is caused by
the disruption of SLN cues. ↓ Disruption is caused by inhibition of the globus pallidus internus (GPi)/
substantia nigra pars reticulata (SNr) pathway resulting in decreased rhythmic control. H2. A disconnect
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between the basal ganglia and the supplementary motor area or cross talk to basal ganglia. ↑ In
normal function, BG-SMA sends internal cueing for automatic initiation of previously learned tasks. X In
PD, FoG is caused by the disruption of BG-SMA cues. This disconnect leads to the inability to
multitasking. ⇡ The increased inhibitory output from deep cerebellar nuclei (DCN) further prevents the
execution of habitual responses. ⇞ In PD, crosstalk between the input to BG from the cognitive, motor,
and limbic cortices may also trigger FoG. ⇏ Firing in the output nuclei of the BG inhibits MLR leading
to FoG events. H3. Knee-trembling and the abnormal coupling between posture and gait. ↑ In normal
function, BG-SMA sends internal cueing for the automatic initiation of previously learned tasks. Because
of the dopamine depletion, executive function is lost. X The BG then fails to convey appropriate
anticipatory postural adjustments. ↓ The breakdown of coupling between posture preparation (at the SMA)
and step initiation (in the Motor cortex) might occur at the pontomedullary reticular formation (PMRF),
which plays a role in postural control and regular locomotion. ↓ The hyperdirect pathway (SMA-STN)
becomes engaged as a result of the coupling breakdown activating the GPi/SNr pathway. ⇡ Additionally
affecting cerebellar automatic gait processing. ↓GPi/SNr oscillations may underpin characteristic 3-8 Hz
knee-trembling. H4. A perceptual malfunction and slowing down when passing doorways. ↑In normal
function, the dorsal stream takes visual information to the occipitoparietal stream, where somatosensory
signals are then transferred to the frontal lobe for the origination of motor function intent. X In PD, FoG
events are caused by dysfunctional dorsal stream processing, which consequently causes inappropriate
adaptation of locomotion. H5. A Consequence of frontal executive dysfunction. ⇞ In PD, FoG events
are caused by a disconnect between the frontal lobe and the BG. This disconnect results in poor
performance of multiple consequent tasks and the characteristically low frontal assessment battery and
verbal fluency scores.

The first hypothesis states that the characteristic gait features associated with FoG are
caused by abnormal control outputs from the central pattern generators (CPG) in the spinal
cord [6], Figure 1 H1. The CPG is a neural network in charge of goal-directed motor output
independent of external timing cues, or sensory feedback [62]. In addition to rhythmic
control, the CPG also receives commands from the supraspinal locomotor network, which
is made up of the primary motor cortex, the supplementary motor cortex, the parietal
cortex, the BG, the subthalamic nucleus, the mesencephalic locomotor region, and the
cerebellum[63]. In PD, FoG events may be caused by a disruption of the supraspinal
control cues to the CPG, which are crucial for turning, stopping, maneuvering obstacles,
and adapting to new locomotion goals [8]. This explanation takes into consideration the
fact that in the control pathway of healthy individuals, the sensorimotor striatum that is in
charge of habitual behavior [64], is inhibited by the substantia nigra pars compacta (SNc)
through D2 dopamine receptors, which are involved in locomotion, learning, memory, and
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reproductive behavior [65]. During normal operation, inhibition of the striatum results in
inhibition of the globus pallidus pars externus (GPe). The active GPe then allows for
inhibition of the globus pallidus internus/substantia nigra pars reticulata pathway
(GPi/SNr) resulting in the execution of previously learned tasks [66]. In the case of PD,
the lack of synergy between dopaminergic modulation networks leads to inhibitions of the
GPi/SNr pathway resulting in decreased rhythmic gait control [8], [66]–[69]. Although not
specifically directed to the focus of this review, it is worth noting that the formerly popular
direct/indirect

pathway’s

simplistic

assumptions

regarding

loops

and

purely

excitatory/inhibitory connections have been questioned and debunked to a significant
extent [70].
The second mechanistic hypothesis underlying the pathophysiology of FoG states that
due to the disconnect from the BG to the SMA, the internal cueing that automatically
initiates previously learned movements is interrupted [71], Figure 1 H2. Some studies
considered that FoG might be due to the loss of automatic updating of motor programs by
the dysfunctional BG in PD [54], [67], leading to the inability to multitask[8], [68].
Furthermore, because of the increased competition between the excitatory output from the
STN, increased inhibitory output on the deep cerebellar nuclei hinders the ability to rely
on previously learned habitual responses [8], [69]. Moreover, FoG might be triggered by
crosstalk of complementary, yet competing, BG inputs from motor, cognitive, and limbic
cortical areas [8]. In this model, the synchronous firing in the output nuclei of the BG leads
to increased inhibition in brainstem locomotor areas and consequently to FoG events [69].
The associative striatum and frontal-parietal cortices are relatively spared early in the
disease course, allowing PwP who exhibit FoG (PDFoG+) to operate gait through goal-
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directed strategies. However, as a result, their gait becomes less automated and vulnerable
to interference from concurrent task demands that can disrupt gait control [68].
From the observation of the characteristic knee-trembling during FoG,

the third

hypothesis states an abnormal coupling between posture and gait, which leads to multiple
anticipatory postural adjustments (APA) preceding FoG events [8], [72], [73], Figure 1 H3.
This finding suggests that the inability to couple normal APAs with the stepping motor
pattern is what causes FoG events in PD during a forward imbalance. APA needed for
normal gait initiation, resulting in a frozen state of attempted readiness [74]. Breakdown in
the coupling between posture preparation by the SMA and step initiation by the motor
cortex might occur in the pontomedullary reticular formation [8], [72]. The hyperdirect
pathway likely becomes engaged as a result of increased response conflict, activating the
GPi/SNr while also disrupting cerebellar processing involved with automated gait
modulation. Altered 3-8 Hz oscillations between the STN and GPi may also underpin the
characteristic ‘trembling in place’ often observed during FoG [18], [75].
The fourth hypothesis states that the FoG event is caused by a perceptual malfunction,
which in association with online planning, causes PDFoG+ to decrease speed as a response
to the visual input related to locomotion planning [76], [77], Figure 1 H4. Almeida and
Lebold found decreased step length and increased gait variability while approaching a
narrow doorway, for PDFoG+ [78], [79]. However, the previous study showed that
PDFoG+ do not overestimate door widths more than PwP who do not exhibit FoG
(PDFoG-), instead, they misjudge the speed reduction resulting from passing through
doorways [80]. The inappropriate activation of locomotor adaptation is considered as the
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result of dysfunctional dorsal stream processing [81], which helps with spatial location and
guides movement response [82].
The fifth hypothesis states that FoG is a consequence of frontal executive dysfunction,
where there is a disconnect between the BG and the frontal lobe, resulting in poor
performance when trying to achieve multiple tasks, Figure 1 H5. This is further supported
by low scores in frontal assessment battery scores and verbal fluency in PDFoG+ compared
to PDFoG- [18], [75], [83]. Extra-nigral pathology impairs compensatory attentional gait
strategies and contributes to levodopa resistant FoG, especially with PD progression [68].
The various hypotheses are a testament to the complexity of the underlying mechanisms
of FoG, likely the heterogeneity of contributing factors among patients. Therefore,
continued exploration of the pathophysiology of FoG in PD is needed. Moreover, not all
PD who exhibit FoG events are triggered by the same causes or respond equally to
medications or therapy. Those who may only experience events when not under
observations, make FoG evaluation and understanding in the clinic elusive [18]. This
review concentrates on dissecting the previous works that relied on electrophysiology to
analyze neural biomarkers associated with FoG. For neuroimaging studies delving into PDFoG, the reader is encouraged to refer to the recent review papers [47], [48].

2.2

Literature and Research Methods

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
statement [84], the eligibility criteria for articles included those published before March
2020, written in English, and currently under published status as journals or full-length
conference articles. PubMed was used as the primary information source with the following
search query “EEG OR LFP AND Parkinson's Disease AND Freezing of Gait”. The search
12

query was conducted by two (2) independent authors who then combined the resultant
findings. This search yielded a result of 34 articles from which 10 articles were removed.
Six were removed as the terms “Freezing of Gait”, “EEG”, or “Parkinson's Disease” were
used during the introduction part but not as part of the research objective [25], [85]–[89],
the other four were removed because the articles did not focus on electrophysiology for its
methods [35], [90], because the article was either a poster abstract and not yet a full
publication [91], or because the article did not deal with human subjects [92]. To
complement the neurophysiology review aspect of this paper, in addition to the articles
found through the PubMed search, sources such as Scopus or Google Scholar were used
when clarifications were needed.

2.3

Neurophysiological Studies of FoG

Recent advances in wearable electronics and computing have allowed for the
miniaturization of electronics and the transition from bulky instrumentation to wearable
and non-intrusive tools. This shift has allowed for neural biomarker explorations in
environments that closely match everyday activities [93] and even allowed for the
implementation of protocols during states of high activity, such as walking [94], [95] and
cycling [96], [97]. Such daily activity paradigms allow for a more precise interpretation of
results because parallel functions in studies using motor imagery [98] or treadmill
walking[86] have to be considered. Furthermore, the constraints of simplified tasks of
finger/wrist flexion to avoid motion artefact [99], [100] are no longer a big concern [68],
[101], [102]. Furthermore, although some of the studies resulting from the PubMed query
did not rely on wearable systems for their instrumentation, their findings can be translated
into current and future studies using such wearable technology. This review begins with
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the cortical studies that use EEG to explore neural biomarkers and/or behavioral measures,
then moves deeper into subcortical studies while discussing the relevant cortical and
subcortical loop connections
2.3.1

Cortical Level

Locomotion is a complex process involving gait initiation at the cerebral cortex and
automatic rhythmic execution regulated by the brainstem and spinal cord. Another
important contributor is the simultaneous predictive control through feed-forward
processing by the cerebellum. These intricate mechanisms may account for the lack of
consensus in FoG pathophysiology, given that exploring the complete projection system
results in an overwhelming analytical task. The difficulty to selectively study individual
networks or components arises because these networks are all inter-relatedly engaged
during real-life locomotion. In the case of EEG, pyramidal cells account for most of the
scalp-recorded electrical signals. This non-invasive tool is thus frequently used in the
exploration of the cerebral cortex, which is shown as the processing center for
proprioception, predictive operations [103], and APA [104], [105]. Of the 24 resulting
studies from the search query, 16 studies used EEG in their approach to detect or predict
FoG events or study neural changes with FoG.
For FoG biomarker exploration, several studies have focused on the study of the cortical
activity associated with self-paced upper limb motion in EEG [50], [99], [106]–[108]. A
negative potential, which starts 1-2 seconds before the limb movement, has been found in
EEG electrodes over the central area, namely the readiness potential or BP. The BP is a
part of the slow cortical movement-related potentials and is followed by the pre-motor
positivity [109]. Early BP, which occurs 1-2 s before limb movement, is associated with
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activation from the pre-supplementary motor area (pre-SMA), SMA, and Brodmann area
6 [109]. The late BP that occurs between 400-500 milliseconds before limb movement is
associated with activation of the primary motor cortex [110]. Studies have demonstrated
that the amplitude of early BP is reduced in persons with PD compared to healthy controls
[108], [111], [112]. In contrast to the amplitude reduction in the early BP, late BP amplitude
is increased in PD compared with healthy persons. The increased BP amplitude may
indicate a compensation mechanism used to achieve limb control in the absence of
information handover from the BG to the SMA [108]. These results have been largely
reproduced only in persons with PD while performing upper limb tasks [109], due largely
to motion artefacts abundant with movements of other parts of the body. In addition to BP,
Butler et al. investigated the lateralized readiness potential (LRP) associated with cued
response to the target detection tasks [39]. They found a significantly earlier onset and a
larger amplitude of the LRP in PDFoG+ compared to PDFoG-. This indicates excessive
recruitment of lateral premotor areas due to the loss of automatic motor control. Their
finding is in agreement with the second mechanism hypothesis, suggesting that deficit in
attentional set-shifting is caused by loss of automatic updating of motor programs due to
the dysfunctional BG-SMA pathway [8], [39], [68].
Previous studies related to lower limb control have mainly investigated the difference
between participants with PD and healthy controls [113]. Relations between stride length
changes and MRCP have also been explored in PDFoG+ and PDFoG- [114]. The study by
Shoushtarian et al. found that a reduction in the early slope of the MRCP was coupled with
stride length reduction for PDFoG- but not for PDFoG+. Their findings show electrical
evidence that cortical disturbances correlate with stride length reduction in PDFoG-,
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whereas the PDFoG+ showed no stride length relationship [114]. However, this study holds
several experimental design limitations including the short gait cycle duration, consisting
of only 3 steps, which is not enough to guarantee gait programming is generated by
automation instead of attentional strategies. Similar studies on neural signatures of FoG
have focused on evaluating the cortico-muscular relationship between the healthy elder and
PDFoG+/PDFoG- [55], [115]. Among them, Gunther et al. found a pronounced
relationship between EMG and EEG at the beginning of FoG events and voluntary stops.
However, this finding was not discussed in the context of its physiological explanation,
and there was no significant difference between the voluntary stops and FoG events [115].
In addition to the MRCPs, time-frequency analysis is another method for evaluating
neural patterns. This approach involves the evaluation of frequency bands [116], [117],
event-related synchronization (ERS), and desynchronizations (ERD) [118], as well as
information flow to examine how a physical manifestation can be correlated to a neural
occurrence. In the work by Singh et al., theta, and beta bands were evaluated during lower
limb pedaling in PDFoG+ and PDFoG- [119]. Results from this study showed that
compared to PDFoG-, PDFoG+ exhibited an attenuated mid-frontal theta (4-8 Hz) power,
which is associated with impairments in cognitive control [120], [121]. An increased beta
(13-30 Hz) power was also found in PDFoG+ compared to PDFoG-. Because beta-band
oscillations are considered a result of interactions between the frontal region and the BG
[37], [122], [123], an increased beta suggests an increased coupling between the frontal
region and the BG in PDFoG+ as compared to PDFoG-. Moreover, in the study of
electrophysiological signature during actual FoG events, Shine et al. found an increase in
theta band power during FoG episodes within the central and frontal areas [117]. This result
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suggests that FoG is related to the frontoparietal processing of conflict-related signals [46],
[124], [125]. In a later study, the same group found an increase in beta activity over the
parietal area during the transition from normal walking to FoG events. The increased beta
activity indicated that the frontal generated motor plans failed to reach the motor cortex,
resulting in the FoG events [126]. Similar STN coherence findings suggest a relation to
parkinsonian limb tremor frequencies (2-10 Hz), in deep brain recording studies [127].
Further works by Toledo et al. during seated position also found higher high-beta (21-35
Hz) activity during the OFF dopaminergic medication, in the STN for PDFoG+, versus
PDFoG- [37]. During the ON dopaminergic state, the high-beta power in PDFoG+ was
reduced in addition to FoG event cessation. Furthermore, coherence was found between
the low-beta component (at C3 and C4), as well as, the high-beta coherence (between the
STN and the SMA at Cz). Altogether, this study indicated FoG events are caused by a
malfunction of the frontal cortex-BG networks via the motor and associative STN loops
[37].
In addition to the studies of neural correlates between EEG oscillations and lower limb
motor execution, Tard et al. explored motor preparation preceding motor execution, which
is altered in PDFoG+ [128]. In this study, an oddball discrimination task was used to
compare the event-related desynchronization (ERD) and ERS of PDFoG+, PDFoG-,, and
age-matched healthy controls. Results showed that even though all groups discriminated
the target from the random stimuli, as shown by the event-related potential (ERP) following
the auditory preparatory stimuli, no significant beta ERD was observed in PDFoG+
compared to the other two groups. This indicated that although the PDFoG+ correctly
perceived the stimulus, their post-perceptual and integrative processing might have been
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impaired [37], suggesting a physiological dysfunction between the frontal cortex and the
BG within the motor and associative STN loops. The BG alterations were related to either
hypersynchronized thalamocortical activity or reduced BG involvement [129], [130].
Additionally, the longer ERS in PDFoG+ is a marker of the high power beta oscillation in
the STN, which results from the corticosubthalamic synchronization at the midline area
[131]. In a visual feedback study, Velu et al. studied the cortical information flow between
the occipital (Oz), parietal (P4), and motor (Cz) networks between six healthy controls and
two PDFoG+ (one who was responsive to the visual feedback and one who was not). This
study found a decrease in the beta power band in the response PwP when the visual cues
were presented. Furthermore, the responsive PwP showed an increased beta band
information flow from the visual area to the motor area, from the visual area to the parietal
area, as well as, a decrease in the power of delta and alpha bands. The beta band power
decrease and information flow findings suggest a correlation between the visual cue and
movement initiation [132].
2.3.2

Subcortical Level

Utilizing EEG for gait exploration is a noninvasive way of analyzing the initial phases
of locomotion, which are generated at the cerebral cortex. However, after the gait is
initiated, thalamocortical, corticobrainstem, and spinal projection produce motor programs
that result in rhythmic gait control [105]. Additionally, both the pedunculopontine nucleus
(PPN) [44], [105], [133] and STN [37], [40], [42], which are located deep in the brainstem,
have been considered to be largely involved in the gait failure for persons with PD. Among
the 24 studies from the search query, eight studies used subcortical recordings to either:
study the deep brain stimulation (DBS) frequencies that resulted in the most FoG reduction
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[134]; or evaluate frequency band changes during the seated state [37], stepping as a
walking surrogate state [42], [44], bicycling state [43], [97], or during an active walking
state [40], [41].
Anidi et al. investigated whether beta oscillations can be used to differentiate PD FoG
phenotypes under no DBS, DBS at 60 Hz, and DBS at 140 Hz frequencies from eight
PDFoG+ and four PDFoG-. They observed that the beta burst durations were significantly
longer in PDFoG+ compared to PDFoG- when walking in place or forward walking.
Additionally, for PDFoG+ during stepping while freezing beta bursts were longer than
during stepping without freezing. Both 60 and 140 Hz DBS stimulation resulted in
improved gait arrhythmicity in freezers compared to no stimulation. During stepping in
place, 60Hz and 120Hz stimulation attenuated beta burst power. Though 60 Hz stimulation
had a greater effect in reducing the beta burst power, both stimulation frequencies
attenuated the beta burst power during forward walking [134].
Toledo et al. reported a relationship between STN activity and EEG frequency
coherence while subjects were sitting. During the OFF state with deprivation of levodopa
administration, PDFoG+ showed higher high-beta (21-35 Hz) activity in the STN
compared to PDFoG- [37]. During the ON state with levodopa administration, similar highbeta levels were found in both the PDFoG+ and PDFoG- groups. They considered that the
high-beta power reduction may have been mediated by levodopa administration which also
suppressed the FoG occurrence. Altogether, this study provided a solid basis to support the
pathophysiological mechanism leading to FoG, indicating that FoG events are caused by a
malfunction of the frontal cortex-BG networks via the motor and associative STN loops
[37].
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In experiments where movement is restricted due to the recording setup or the movement
artefacts contamination [42], stepping in place is used as a surrogate for actual gait, because
stepping involves both balance control and rhythmic activity similar to the actual gait.
Moreover, stepping in place is even susceptible to FoG events [22], [135]. The following
two studies implemented stepping in place paradigms as surrogates for active gait, one
focusing on the changes to the PPN [44] and the other on changes to the STN [42]. Fraix
et al. explored the oscillatory changes of the PPN in seven PDFoG+ with DBS. Their study
included DBS recordings of bilateral PPN and cortical needle EEG at central and frontal
areas. Their main finding was increased alpha (5-12 Hz) oscillations during stepping in
place while ON levodopa compared with OFF levodopa. Contrary to other studies, they
reported a beta power decrease while ON levodopa compared with OFF levodopa. This
discrepancy was attributed to differences in the experimental setup as well as the long
duration of STN DBS stimulation, which could have led to plastic changes in the PPN.
This study also reported decreased gamma activity in the PPN while ON levodopa. This
decreased gamma-band activity was associated with increased PPN-Cortical coherence in
the gamma band. These findings supported increased phase locking between the cortex and
the PPN in the gamma band, which is in agreement with an MRI study showing a direct
pathway between the PPN and the frontal cortex [44], [136]. Fischer et al. investigated
neural dynamics in the STN in persons with PD while subjects were seated and stepping in
place. Their main findings include a suppression in the beta band (20-30 Hz) after
ipsilateral heel strikes, which was distinct between the left and right STN sites when
alternating stepping cycles. Furthermore, this study found that the auditory cueing resulted
in an increased beta modulation and more synchronized gait regulation. The increased beta
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modulation leads to the consideration that alternate left-right DBS may redistribute beta
bursts similarly to auditory cueing [42].
Bicycling is a novel experimental paradigm used to elicit movement-related neural
responses with less movement artefact contaminated compared to actual gait. Research has
shown that PDFoG+ may bicycle regardless of their severe walking alterations [96]. Recent
findings also show that cycling even promotes acute and sustained symptom improvement
[137]. Bicycling was associated with a stronger sustained cortical activation as indicated
by a high beta power decrease. Meanwhile, cortical motor demand was decreased during
sustained cycling [43]. In the works by Gratkowski and Storzer, a decreased beta-band
activity was observed in the STN from DBS leads. A similar beta decrease was also
detected using scalp EEG from parietal and occipital areas [97]. Later, Storzer et al.
observed a reduction of beta power in the STN during cycling compared to walking in both
PDFoG+ and PDFoG- groups during the OFF state. Additionally, an 18 Hz power increase
was observed in PDFoG+. The low beta-band activity was considered as either a signature
of the affected BG or as a movement-inhibiting signal in the motor network [138].
Lastly, as FoG is an event that is mostly triggered during actual walking acquiring
subcortical neural biomarkers during active gait paradigms is paramount. During their
active gait paradigm, Syrkin-NIkolau et al. compared stepping in place, forward walking,
and instrumented walking, which included a turning and barrier course. During stepping in
place, a decreased STN beta band power was found in the PDFoG+ compared to the
PDFoG-. Additionally, an increased beta sample entropy, which is a measure of
unpredictability, was found in PDFoG+ compared to the PDFoG-. During FoG events,
increased alpha sample entropy and decreased beta power was found compared to walking
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without FoG. The increased sample entropy in the PDFoG+ group indicated an increase in
the error of the processing of sensorimotor information in the subthalamic outflow. On the
other hand, the pattern of low beta power and high beta entropy may be caused by a
compensatory mechanism adopted to overcome abnormal gait [41]. In addition to cued
active gait paradigms, dual-task protocols have also been utilized to explore subcortical
biomarkers of FoG. In their work, Chen et al. recorded local field potentials (LFP) from
the STN while subjects performed either single or dual-task walking. In this study, FoG
vulnerability was derived from accelerometers located at the subjects’ trunks. Their results
showed an increased LFP power in the low beta and theta bands irrespective of single or
dual-task walking. The increased power in the low beta and theta bands were found to be
associated with FoG vulnerability. Their findings further support the second mechanism
hypothesis, stating that cross-talk between motor, cognitive, and limbic circuits results in
synchronous firing from the BG resulting in FoG events [40], [69].
While electrophysiological studies provide an excellent route to capture dynamic loss in
cortical connectivity with freezing in PD, electrical measures provide a limited
understanding of the cortical-subcortical connectivity and whether there are homogeneous
losses in brain structure within PDFoG+. PET and MRI provide a means to study the loss
of brain structure in PDFoG+. These neuroimaging techniques have been extensively
utilized to understand the pathophysiological mechanisms of PDFoG+ [47], [48], [139].
Converging evidence from these neuroimaging techniques suggests that subthalamic
locomotor regions, cerebellar locomotor regions, and mesencephalic locomotor regions
may be involved with FoG. This review is focused on the electrophysiological findings
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related to PDFoG+, in which the studies of imaging findings are excluded. However,
excellent reviews on imaging technology can be found in recent papers [47], [48], [139].

2.4

Summary of Findings

2.4.1

Differences in EEG Between PDFoG+ and PDFoG-

Table 1. summarizes the studies that focused on differentiating PDFoG+ vs PDFoG- for
developing potential biomarkers. For PDFoG+ the LRP in EEG was shown to have an
earlier onset and a larger magnitude during cognitive decision making of target detection
compared to PDFoG-. These findings support the second mechanistic hypothesis, which
states that dual-task triggered FoG events are caused by the loss of automatic updating of
motor programs by the dysfunctional BG [39]. In terms of EEG frequency band analysis,
the beta band was shown to increase in the frontal region during lower limb pedaling in
PDFoG+, indicating preparatory adjustments and motor plan execution through top-down
signaling [140]. Also, for PDFoG+ theta band power was attenuated in the mid-frontal
location, indicating an impairment in cognitive control [119]. In the study that used the
dual-task oddball paradigm, although the stimulus was detected by an increased P300, beta
ERD was unchanged for PDFoG+. The inability of PDFoG+ to react to stimuli might have
been caused by impairments at the BG. The BG impairments were suggested to either be
caused by reduced input to the sensory-motor cortex or by the hypersynchronized
thalamocortical activity. Additionally, the duration of beta ERS was found to be longer
after the cue signal in the PDFoG+ compared with PDFoG- [128].
2.4.2

Difference STN Activity Between PDFoG+ and PDFoG-

When delving into subcortical studies and LFP, an increased high-beta (21-35 Hz)
power was observed in the STN during the OFF state in PDFoG+. Levodopa administration
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was found to effectively reduce the high-beta power [37]. In the study on the power
coherence between the STN and EEG, the beta burst’s duration was longer in PDFoG+
compared with PDFoG- during stepping in place and walking forward [134]. In the
bicycling and walking study, the greatest beta band decrease was observed during cycling,
indicating its potential therapeutic effect by matching the effects of DBS therapy [138].
Finally, beta power was decreased during stepping without FoG and was proposed to
indicate a compensatory mechanism adopted to overcome abnormal gait in PDFoG+. This
study also explored sample entropy and found it to be at its greatest during forward
walking. This indicated an error in the processing of subthalamic outflow, resulting in
abnormal gait patterns [41]. The vast variety of biomarkers and competing results are
suggestive of the need for future research to follow similar paradigm and evaluation
procedures. For findings to be significant, future research needs to agree on the way bands
are segmented, i.e. beta into high and low bands. Also, to more closely match potential
FoG event occurrences, more work is needed to focus on actual lower limb task paradigms
and the execution of protocols during ON vs OFF medication states.
Table 1. Results and interpretation of studies that compared neural biomarkers of PDFoG+
vs PDFoG-.
TITLE

PROTOCOL

MOTOR
PREPARATION
RATHER THAN
DECISION-

Detection
differences
cognitive
decision

METRIC

of LRP
in
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FINDINGS

INTERPRETATION
(HYPOTHESIS
SUPPORTED)
Earlier onset Excessive recruitment of
in PDFoG+ lateral premotor areas
compared
due to loss of automatic
with PDFoG- motor control (2nd)

MAKING
DIFFERENTIAT
ES
PARKINSON'S
DISEASE
PATIENTS
WITH
AND
WITHOUT
FREEZING OF
GAIT[39]

making by EEG LRP
recording
during timed
response target
detection

FRONTAL
EEG recording
THETA
AND during lower
BETA
limb pedaling
OSCILLATION
S
DURING
LOWER-LIMB
MOVEMENT IN
PARKINSON'S
DISEASE[141]

Larger
magnitude in
PDFoG+
compared
with PDFoG-

Theta (4-8) Attenuated in
Power
the
midfrontal
location
in
PDFoG+
compared
with PDFoGBeta (13-30 Increase in
Hz) Power the
frontal
location
in
PDFoG+
compared
with PDFoG-

Associated
with
impairments in cognitive
control (5th)

Altered
preparatory
adjustments and motor
plan execution through
top-down signaling (5th
or 3rd)

HIGH
BETA
ACTIVITY IN
THE
SUBTHALAMIC
NUCLEUS AND
FREEZING OF
GAIT
IN
PARKINSON'S
DISEASE[37]

EEG and deep High-Beta
Brain electrode (21-35 Hz)
recording
during seated
position

Higher STN
activity
during
the
OFF state in
PDFoG+
compared
with PDFoG-

Associated
with
interference in the frontal
cortico-BG loops which
suggests a predisposition
to freeze (2nd)

ATTENTION
MODULATION
DURING
MOTOR
PREPARATION
IN
PARKINSONIA
N FREEZERS: A
TIME-

Discriminatory Beta ERD
attentional dual
task
as
mediated
by
oddball
paradigm using
EEG, for the
time preceding
gait initiation

Not present in
PDFoG+
compared
with PDFoG-

Associated
with
impairments of the BG,
as
either
hypersynchronized
thalamocortical activity
or
reduced
BG
nd
involvement (2 )

25

FREQUENCY
EEG
STUDY[128]

Beta ERS

Prolonged in
PDFoG+
compared
with PDFoG-

A cortical marker of the
high-power
beta
oscillations
in
the
subthalamic
nucleus
during FoG (2nd)

NEUROMODUL
ATION
TARGETS
PATHOLOGIC
AL
NOT
PHYSIOLOGIC
AL
BETA
BURSTS
DURING GAIT
IN
PARKINSON'S
DISEASE[134]

Walking
in Beta (13place
and 30) Burst
forward
walking
comparison of
DBS frequency
setting effects
while recording
STN and EEG
power
coherence

Prolonged in
PDFoG+
compared
with PDFoG-

Reflect
beta-band
oscillations in the STN
which are representative
of FoG (2nd)

BICYCLING
SUPPRESSES
ABNORMAL
BETA
SYNCHRONY
IN
THE
PARKINSONIA
N
BASAL
GANGLIA[138]

Comparison of Beta (13-35
subthalamic
Hz)
features OFF
medication
during
18
Hz
bicycling
Power

Reduced in
PDFoG+
compared
with PDFoG-

Reduces
interference
between
cortico-BG
loops, thus reducing FoG
risk (2nd)

Increased at Indicates susceptibility
movement
to freezing caused by
onset
in movement-inhibition
PDFoG+
throughout the motor
compared
network (2nd)
with PDFoGSUBTHALAMIC STN activity Beta (13- Decreased
Compensatory
NEURAL
comparison
30) Power
during
mechanism adopted to
ENTROPY IS A during stepping
stepping in overcome abnormal gait
FEATURE OF in
place,
PDFoG+
(2nd)
FREEZING OF forward
compared
GAIT
IN walking. and
with PDFoGFREELY
instrumented
Sample
Increased
Increase in error of the
MOVING
walking
Entropy
during
processing
of
PEOPLE WITH
forward
sensorimotor
PARKINSON'S
walking
in information
in
the
DISEASE[41]
PDFoG+
subthalamic outflow that
compared
results in abnormal gait
with PDFoG- patterns (1st or 2nd)
Results and interpretation of studies that compare neural biomarkers of PDFoG+ vs. PDFoG–.
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2.4.3

Difference in the Electrophysiological Activity Between ON and OFF

Medication
From the 2 studies resulting from the search query, one examined the effects of
parkinsonian medication. The results from such explorations can even be used to support
some of the hypotheses by evaluating the known effect of the medication and the symptom
alleviation provided. For example, high-beta power reduction was shown to be mediated
by levodopa administration resulting in FoG cessation. This high-beta power reduction
resulted in similar oscillatory high-beta levels between the PDFoG+ and PDFoGgroups[37]. This finding supports the fifth mechanistic hypothesis, which states that FoG
events are caused by a malfunction of the frontal cortex-BG networks via the motor and
associative STN loops. This study also found high-beta coherence between the STN and
the SMA, which supports the association between the hyperdirect pathway and FoG event
triggering. However, dopaminergic medications are not effective for all who develop FoG
and may even trigger FoG events, as in PDFoG+ who experience FoG even ON-levodopa.
Recent studies have shown that dopaminergic medication improves gait speed, stride
length, and reduces freezing events but does not improve gait asymmetry and gait
arrhythmicity[19], [142], [143]. Premovement EEG beta desynchronization is reduced in
PDFoG+, and this abnormality is at least partially mitigated by dopaminergic
stimulation[11], [73], [143]. Additionally, cholinergic loss in the pedunculopontine
nucleus may play a role in FoG, as it stands at the crossroads between supraspinal and
spinal gait centers[73]. fMRI studies to understand the effects of dopamine on corticalsubcortical connectivity within PDFoG+ is an active area of research[144] and may be able
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to distinguish cortical-subcortical connectivity changes between dopamine responsive
PDFoG+ and dopamine non-responsive PDFoG+.

2.5

FoG Event Detection

In addition to the application of biomarker research, EEG may also be used to detect
and even predict FoG events. From the search query, the earliest works employed four
channels of wireless EEG systems for FoG event detection [125]. In this work, the wavelet
decomposition method was used because of its adaptable and adjustable characteristics that
allow for time-frequency localization, multiscale zooming, and multi-rate filtering [125].
A three-layer backpropagation neural network was used with the highest classification
accuracy of 76.6% while relying only on the P4 channel. The success rate of classification
between normal and freezing onset implied that the FoG event could be detected from the
neural signature as far back as 5 seconds before the physical representation. This work was
further advanced to incorporate spatial, spectral, and temporal features as well as a kNearest neighbor classifier to bump classification accuracy to 80% [53] then 87% [124].
The electrodes detected to be most sensitive to the transition of freezing, namely P4 and
Cz, support the finding that freezing impacts the medial parietal areas, which are in charge
of integrating sensory information and visuospatial processing [145]. Other FoG event
detection studies relied on effective brain connectivity to boost classification accuracy by
up to 94.8% [126]. In this study, findings suggest that hypersynchronization is generated
by the frontal region, which is critical for spatial attention, motor intention, cognition, and
decision-making processes. These results support the fifth hypothesis underlying FoG,
which states that FoG is a consequence of frontal executive dysfunction, where there is a
disconnect between the BG and the frontal lobe, resulting in poor performance when trying
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to achieve multiple tasks [18], [54], [68]. Later studies have also focused on the electrode
placement, suggesting an optimal montage of 2 channels, located at C4 and O2 [146].
Meanwhile, others have focused on turning freezing detection (TF), which is a subtype of
FoG, to improve detection classification from 68.6% [116] to 86.2% [147]. The latest of
these studies focused on expanding on the feasibility and robustness of FoG detection with
EEG by examining data from more subjects, resulting in a sensitivity and specificity of
82.7% and 86.6% respectively [148]. These studies concluded that FoG can be detected
and even predicted through the underlying EEG signature with high certainty and a low
EEG channel count.

2.6

Conclusion

The main aim of this review was to highlight the most recent mechanisms underlying
FoG in PD through electrophysiological explorations. The results from these cortical and
subcortical level studies can be used to enhance the understanding of PD pathophysiology.
Additionally, the high temporal resolution of EEG may be combined with the high spatial
resolution of other modalities to understand subject-level cortical-subcortical connectivity
in PDFoG+, which may be further combined with diffusion and structural MRI, to
understand if there is any backbone anatomical network[149] within PDFoG+ attributing
to freezing in such patients. These multimodal approaches may be better able to
characterize structural and functional abnormalities within PDFoG+ at an individual level
and may pave the way for the identification of potential therapeutic targets to alleviate
PDFoG+. From the studies discussed, most FoG exploration studies relied on gait surrogate
paradigms due to instrumentation limitations or resultant motion artefacts from active gait.
The application of state-of-the-art wearable medical devices will allow for unconstrained
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paradigms with true-to-life triggers and settings[150], which will bring an enhanced
understating of PD pathology. Additionally, the combination of real-time neural recordings
along with physiological sensing and stimulation will permit closed-loop systems to detect,
correct, and even predict FoG events. Future works should then focus on implementing
active gait paradigms along with real-life settings to detect actual FoG events. Top-down
sensor implementation will then allow for biomarker detection and verification by neural
signature confirmation, as biomarkers must relate not only to the resultant physiological
response but also to the neuronal mechanism in charge of motor control.
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CHAPTER 3 THE SENSOR APPROACH

3.1

Introduction

Over a century ago, Richard Caton was the first to develop a visualization of the
electrical current measured by positioning electrodes at the surface of a skull. About 45
years after this initial discovery, Hans Berger started what is the basis for modern EEG.
His very early findings of alpha waves, sleep spindles, and even early works on epilepsy,
make Berger the father of EEG [151]. To this day, although the acquisition of EEG
waveforms has greatly improved over the century since its birth, electrode performance
still proves to be the most challenging aspect to provide a good quality signal. Although
neural features have been explored for the detection of biomarkers, non-invasive neural
exploration during active gait still proves difficult. This difficulty can be attributed to four
challenges: movement artefacts associated with active gait paradigms, the standard sensing
systems’ cancellation of relevant signals, the inability to achieve volition due to comfort,
and multi-sensory co-registration of wearable sensors. These challenges are augmented in
PD patients who may exhibit tremors, dyskinesia, and other symptoms, further adding to
the motion-corrupting artefacts during active gait. Additionally, due to cognitive decline,
PD patients may not be able to sustain long periods of activity, making long recordings
unfeasible. To successfully capture the neural patterns associated with active gait, the
sensors used for exploration must; be synchronized with each other to co-register neural
and muscular activations; have a recording bandwidth that is sensitive to the features of
cortical potentials; be unobtrusive to ensure executive motor control is not affected by the
sensing system; be ultra-wearable and easy to set up; and allow for movement artefact
attenuation to guarantee signal quality.
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The top-most sensor in the proposed suite is the EEG, able to record electrical potentials
from the scalp. The EEG records neural activity in the range of microvolts and is thus
highly sensitive to motion artefacts. The two main sources of noise in EEG recordings are
stationary noise whose statistical parameters do not change in time, these include white
noise and sinusoidal noise from sources such as power outlets. The second source of noise
in EEG recordings is non-stationary noise, whose statistical parameters do change with
time. This noise can be composed of eye blinks, pulmonary and cardiac activity, and
movement artefacts from physical motion, such as active gait. As this non-stationary noise
is more difficult to filter out, three common methods are employed to deal with these
artefacts: artefact-free sampling, repeated recordings, and the use of hardware designed to
deal with active recordings. Artefact-free recordings are achieved when noisy segments are
removed manually or when one co-register to motion sensors and/or behavioral data to
detect corrupted segments. Repeated recordings may also be employed to rid data of
artefacts. Considering that stationary noise can be simply filtered out, non-stationary noise
may be averaged out over enough recordings. This approach is common practice when
recording MRCP, where typical protocols call for trials repeated 40 to 300 times then
averaged. Lastly, hardware designed specifically for the task of active gait recording may
be used to guarantee artefact-free neural signals. To this effect, several groups and
companies have created proprietary versions of wearable EEG systems. However, some of
these devices are not built to allow for active gait recordings, result in problematic setups,
and high levels of noise [152], [153], or are designed with built-in filters that attenuate
relevant signals in very low-frequency ranges [154]. Additionally, for the active gait neural
exploration, start and stop activity must be synchronized with the EEG activity.
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3.2

Background

To this day, the interface between the scalp and the electrode still proves challenging to
set up properly. This is due to the insulatory characteristics of the scalp which holds oil and
hair, not to mention the skull itself which acts as a low pass filter (Srinivasan 98). Common
EEG practice dictates the removal of surface oil and dead skin cells by rubbing with mild
abrasives [155]. This process is then followed by the insertion of an electrolyte gel,
commonly made of sodium and chloride, which merges the gap between the metallic
electrode and the surface of the scalp, helping to reduce the impedance down to the
acceptable 5 KOhm for individual electrodes and 1 KOhm between electrodes [155]. This
electrolyte also acts as a vibratory dampener by allowing the free flow of ions even when
the electrode tip is not in direct contact with the scalp. This interaction results in an electric
double layer, which is made by the lining up of opposing charges between the electrolyte
and the metallic electrode, increasing capacitance and improving the flow of current
created by the electrical fields under the skull [151]. However, with applications requiring
an increasing number of electrodes, the preparation and setup of gold standard devices can
take a single experimenter 40 minutes for a 64-channel wet electrode system [156]. Also,
because the electrolyte is generally water-based, it dries out within a couple of hours of
setup and is also susceptible to dilution by sweat, thus reducing its main conductive
benefits.
The long setup required, susceptibility to signal quality decrease over time, and
discomfort to the user have led to a shift towards “dry” electrodes. These are commonly
made of similarly inert metals such as gold, or of silver-silver chloride electrode-covered
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tips. However, unlike wet electrodes, these rely merely on mechanical contact with the
scalp to provide the necessary interface for the flow of current.

3.3

Proposed Solution

For the exploration of neural activity during active gait, reliable noise-free data is
needed. To solve the sensor approach challenges the following requirements were
established: the suite would have been able to detect neural features during active gait, it
had to be wearable and not interfere with normal function, and all the sensors within the
suite needed to be time-synchronized. This study proposes a whole-body suite to
encompass the EEG activity from the head recorded at the surface of the skull, Figure 2a,
2b, and 2c. Alongside EEG, the electrical activity from the muscles involved in gait control
Figure 2d, as well as the kinetic and kinematic features associated with the gait phases
during locomotion, Figure 2e. Additionally, following Stuart’s recent review on cortical
(a)
(b)

activity identifiers for the elder and those PwP,
the relationship between the neural activity and
behavioral outcomes should also be consistently
recorded

(f)

and

reported

[51],

to

achieve

behavioral tracking, an upper limb device,
(c)

which records bradykinesia using an angle

(d)

sensor at the perlicue, was designed and tested

(e)

for clinical use as a companion to objectively
assess

disease

progression,

Figure

2f.

Figure 2. The complete sensor suite, custom-made for active gait neural exploration. (a) The
custom wet Ag-AgCl electrodes with low noise, (b) EEG electrode array with short cabling for
artefact reduction, (c) wearable EEG sensor with wireless connectivity; (d) electrical activity from
the muscles; (e) kinetic and kinematic activity from gait; (f) behavioral and symptom tracking.
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Successful neural activity exploration is contingent on robust and reliable synchronicity
between the EEG, EMG, GRF, and upper limb symptom analysis devices. The following
section will cover the devices that make up the ultra-wearable suite. Each subsection will
encompass each of the devices and the specifications that warrant its inclusion into the
proposed suite.

3.4

Sensors Development

3.4.1

Wearable EMG

Figure 3. shows the EMG system which will synchronously record electrical potential
from the surface of the skin. For this, a lightweight, low-power consumption, batterypowered, and wireless-enabled sensor, using an ADS1292 chip, will be employed. The
analog-to-digital converter ADS-1292 module is a low-noise 24-bit analog front-end
biopotential measurement system by Texas Instruments (Dallas, TX, USA). A 32-bit MPU
(CC3200) with built-in Wi-Fi connectivity was employed for on-board real-time signal
processing and data transmission. A high-precision EMG signal allows for less than 0.8
µV of peak-to-peak noise.

Figure 3. EMG system with DAQ and electrodes.
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The custom-made CyberSens device was designed to provide a seamless recording and the
transmission of two channels of a 24-bit EMG signal, with the sampling rate up to 8000
Hz. The wireless transmission can also reach 100 feet in an open space. Likewise, an MPU9250, which meets the requirement for studying human locomotion, was employed for
kinematics and noise estimation. This device has been thoroughly tested in several studies
from our group, with as many as ten individual sensors wirelessly connected, supplying
synchronous muscular activity information for live active-prosthetic tuning and energy
expenditure optimization [157], [158].
3.4.2

16 Channel EEG

Following Lopez-Gordo’s recommendation for electrode description and evaluation the
following sensor characteristics needed to be assessed or ensured for the wearable EEG
data acquisition system (DAQ) and accompanying electrodes. First an Impedance between

electrodes in the range of 5 to 40 K ohms (Typical of 5.6 Kohm). A valid frequency range
along the relevant neural bands. Noise level characteristics and a biosignal application
procedural feature measure.

Figure 4. The EEG system. (Left) 16 channel EEG system mounted on a custom EEG cap.
(Right) The top image shows the EEG DAQ with 2 ADS1299s, power management, and
embedded IMU. The bottom image shows the CC3200 for WiFi connectivity and onboard
storage.
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At the core of the EEG DAQ is the microcontroller, Figure 4. For this, on-board realtime signal processing, and wireless data transmission, the 32-bit CC3200 multi-core
processing unit, capable of WiFi connectivity, was used. This device provides seamless
recording and transmission of sixteen channels of 24-bit EEG signal with a sampling rate
of up to 1000 Hz per channel. The range of the wireless transmission can reach about 100
feet in an open space, allowing for natural walking made of voluntary starting and stopping.
For digital to analog conversion, two ADS1299s were used in cascade mode. This
configuration is beneficial because although it requires more general-purpose input/output
pins than the Daisy-chain mode, multiple readback mode is sustained. Benefits of the
ADS1299 (Dallas, TX, USA) include a low required minimum signal bandwidth, of 10μVPk, an input impedance of more than 10 MΩ, lead-Off detection, programmable gains,
and an input-referred noise of 1.0 µV peak-to-peak. In a dorsiflexion and active stepping
experiment, by Rashid et al. A comparison was made between the ADS1299 and the
NuAMPS gold standard EEG system. Comparable signal quality was found for the premovement noise, which represents the EEG activity from 2–3 s before the EMG onset,
regarded as a baseline in MRCP and ERD/S patterns. Also, comparable signal-to-noise
ratios (SNR) were found during both tasks. In this study, the SNR was defined as the ratio
of peak negative amplitude to the root mean square value in the baseline segment of the
averaged MRCP, expressed in decibels [159]. This comparison study functioned as
validation for the use of the ADS1299 in our wearable suite.
Further, an inertial measurement unit (IMU) was also embedded in the EEG system.
The MPU 6050 (gyroscope + accelerometer+ magnetometer) micro-electro-mechanical
system by InvenSense was employed for kinematics data acquisition. This chip provides a
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user-programmable gyroscope full-scale range from ±250, to ±2,000°/s and a userprogrammable accelerometer full-scale range from ±2 to ±16 g, which meets the
requirement for studying human locomotion. An eight-channel version of this DAQ was
originally developed by our group and has been tested in-depth [56]. The 16-channel DAQ
was designed and built to be used with two sets of in-house built electrodes, dry and wet.
3.4.3

EEG Electrode

Unlike wet electrodes, dry electrodes are easy to mount and have been shown to be
preferred by the wearer over wet electrodes [160]. Methods to provide dry electrodes have
resulted in several electrode types; gold-coated single pin, multiple pins, and solid-gel
electrodes [161]. In Di Flumeri’s comparison, comparable mental state classification and
signals spectra values were found between these three dry electrode types and the wet gold
standard. However, these electrodes were used with proprietary DAQ, this adds a variable
to be considered in their comparison and limits their implementations to sensing systems
that prove as expensive as the wet gold standard [161]. Not only does the inherent design
of the electrodes require specific DAQs, but also, because there is no electrolyte, a constant
applied pressure is required, this may lead to discomfort over long recordings overcoming
the benefit of not using an electrolyte [162], [163]. Finally, these dry electrodes are
sensitive to surrounding noise from persons and other electrical equipment [164].
Others have also developed dry electrodes made of micro-needle tips, spring tips, and
conductive polymers [165]. Commercially available examples include those by
BrainProducts, who make a single gold-pin electrode with three variable pin sizes that are
individually sprung, g.Tec, who makes 2 8-pin fixed-length active electrode sets, similarly
Quasar who created an electrode with two sets of rings with spikes and integrated amplifier,
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licensed by Wearable Sensing, and the dry-solid gel-based electrodes also made by
BrainProducts. As discussed, these require independent DAQs and are then bound to
proprietary recording systems. Recently Xing developed and tested a graphene-based
polymer system, which allowed for good SNR and classification accuracy of steady-state
visual evoked potentials (SSVEP). However, the testing was made in the range of 0.1 to
1000 Hz, which although covers a large bandwidth [165], does not span to the lower
frequencies required for motor execution preceding features such as in MRCP that lie in
the 0.05 to 5 Hz range [166].
3.4.3.1 Electrode Development
This study presented a dry EEG sensor with similar quality to the standard wet
electrodes, designed to be interfaced with any other open-source DAQ. Comparable signal
quality to wet electrodes is proposed by applying a mechanical springing mechanism, as
well as, an embedded Faraday cage used to insulate from electrical interference and
motion-related noise.

Figure 5. Four lead, individually sprung dry EEG electrode design. The built-in Faraday cage
allows for outside electrical interference to be isolated, while the spring mechanism allows for
dampening of motion during high activity recordings. All measurements are in mm.
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This mechanism will also act as a dampener that will provide comfort to the wearer. Shown
in Figure 5 is the design of the electrode, which was made using SOLIDWORKS 2018.
The electrode consisted of four individually sprung 12 gauge .925 sterling silver rods that
were chlorinated using the methods suggested by Warner Instruments [167]. Having four
individually sprung contact points allows for constant mechanical contact with the scalp
even under motion and as reported by Symeonidou et al. who found that increasing the
surface area of the electrode has a significant effect on improving EEG signal quality [168].
Each rod had a conical head with a 0.4 mm radius and measured 11 mm from the tip of the
hemisphere that contacted the scalp to the contact at the back where a silver wire was
soldered. The length of the rods was determined by the compression of the springs and the
width of the case that held each silver rod and spring mechanism. This allowed for a
maximum length of 7.25 mm and a minimum of 3 mm under full compression. Following
Hooke’s law, 𝐹𝑠𝑝𝑟𝑖𝑛𝑔 = −𝑘𝑥, each silver rod generated a maximum normal force with the
scalp of 0.618 N, given that the spring used had a spring constant of 145.355 N/m and the
spring was compressed by a maximum displacement of 0.00425 m. For this study, several
springs with differing springs coefficients and lengths were evaluated. A spring with a free
length of 15.75 mm and the above-mentioned spring coefficient was used as it resulted in
a compromise between the wearer’s comfort and a dynamic movement that allowed the
electrode case to be rotated up to 55 degrees. This electrode was designed to be mounted
on the sites of the International standard 10-20 system using a standard EEG cap.
The case that houses the silver rods and the springing mechanism was designed to be
3D printable, this lowers cost and allows for rapid changes to be made and implemented,
Figure 6.
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Figure 6. Dry EEG electrode range of motion. The individually sprung mechanism allows the
silver springs to be exposed up to 7.25 mm from the case during minimal compression and up to
3 mm at full compression. Having four individually sprung silver rods allows for constant contact
with the scalp.

To reduce the impact of external interference, a Faraday cage was designed to be embedded
into each electrode case. The cage is made of a thermoplastic composite with copper
strands. The chromium zirconium copper alloy has great thermal and electrical
conductivity, thus reducing external interference and functioning as a thermal sink to
reduce the thermoelectric effect, which is known to change the electrical conductive
characteristics of electrodes [169]. The mechanical aspects have already been described,
these include fundamental physical attributes, materials used, dimensions, and fixation to
the scalp. In terms of electrical attributes, the electrodes proposed will not rely on
embedded amplification.
Due to the high SNR requirement of cortical recorded neural activity and the need to
attenuate motion artefacts through custom short cabling. Custom wet EEG electrodes were
also designed and tested to be used with the custom 16-channel EEG DAQ. Like the EEG
dry electrode, the EEG wet electrode was designed using SOLIDWORKS 2018. After
several rounds of design and testing, a final solution was selected to be made of 4 parts:
the body and sensor cap shown in Figure 7, designed to be 3D printed and easily modified,
and a pair of 12 gauge .925 sterling silver rods that were chlorinated using the methods
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suggested by Warner Instruments [167]. This in-house built EEG wet electrode was tested
using an MRCP evaluation, which was acquired using the complete ultra-wearable solution
and will be discussed in section 3.5.

Figure 7. Two lead, wet EEG electrode. The built-in Faraday cage allows for outside
electrical interference to be isolated, the electrolyte used dampens motion and functions as an
electrical double layer between scalp and electrode. All measurements are in mm.

3.4.3.2 Preliminary Dry Electrode Testing
Standard EEG procedure dictates maintaining impedance between 5k-40k Ω This has
commonly been done by using an abrasive pad to get rid of oil and sweat. However, this
practice is widely being replaced to avoid breaking through the skin. Instead, gold standard
EEG systems use saline and provide electrode-by-electrode impedance measurements.
However, these cost upwards of 10k USD for a 16-channel EEG device. Instead of adding
a circuit to each electrode, which would increase complexity and cost. We used the
ADS1299 built-in lead-off function allowing for either DC or AC stimulation. Our device
could pin-point which electrode does not meet a pre-defined DC value established during
setup. This was done by injecting a known DC through a selected pull-up or down resistor
then measuring the output and comparing the difference. DC lead-off detection can only
be done during power-up, or during a programming state, because the BIAS amplifier must
be powered off. The ADS1299 also possesses an AC signal source with programmable
stimulation current and frequency.
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Figure 8. EEG electrode testing setup. (Left) Dry electrode feature SNR setup with embedded
Faraday dry electrode at O1 and standard wet at Oz. Both electrodes are connected to the inhouse developed 16-channel EEG DAQ. (Right) Visual evoked potential stimulator, designed to
control the flicker of a set of light-emitting diodes. Flicker was verified using an oscilloscope.

By measuring the magnitude of the output at the excitation signal frequency (usually at ¼
of sampling frequency), intermittent impedance can be measured to ensure individual
channels are kept at the desired 5-40k Ohm impedance range. After ensuring the electrode
impedance could be monitored during the setup and the actual recordings. The range of
frequencies and noise characteristics needed to be evaluated. As shown in Figure 8 left,
while wearing a wet and dry electrode in the occipital region, grounded at Afz and
referenced at Fz. One user was asked to perform 10 eye blinks followed by 10 seconds of
eyes closed (to generate alpha activity), and finally, the subject was asked to perform jaw
clenches for 10 seconds.
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3.4.3.3 Preliminary Dry Electrode Results

Figure 9. EEG electrode noise and SNR results. (Top) Frequency range characteristics for both
wet and dry EEG electrodes during an eyes-closed task. (Bottom) Wet EEG electrode signal-tonoise ratio during the eyes-closed task, expected to elicit alpha activity in the 8-12 Hz band.

This test resulted in a higher power spectral density for the wet electrode throughout the
relevant frequency compared with the dry electrode, Figure 9. Additionally, the wet
electrode’s 1.43 dB SNR value fell within the SNR range found in the literature [170]. This
task-specific test showed that the wet electrode outperformed the dry in both SNR during
eye blink and across relevant neural band frequencies. The purpose of this comparison was
twofold. First, to show which electrode was least prone to artefacts from electrical
interference in a noisy environment. Secondly, to highlight the similarity between the wet
and dry electrodes, showing the potential of the dry EEG electrode as a future interface
between the scalp and the EEG DAQ, without the need for long to set up and uncomfortable
gelling.
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In addition to the range of frequency response and noise comparisons, a procedural
neural response with known features needed to be tested using the designed wet and dry
EEG electrodes. For evaluating the performance of the proposed dry EEG electrode, a
comparison between feature SNRs using SSVEP was carried out. Brain-computer interface
systems often rely on neural feedback associated with a stimulus as inputs for control. In
the case of SSVEP, a stimulus with known temporal and spectral properties is employed,
this is then matched to neural patterns often recorded from the visual processing areas of
the brain [171]. To test the performance of the proposed dry EEG electrode, two electrodes
were positioned along the occipital lobe Figure 8 Left, following the international standard
10-20 system. A wet electrode was positioned at Oz and a dry electrode with embedded
Faraday cage at O1. For ground and referencing, two wet electrodes were positioned at
AFz and Fz, respectively. The proposed DAQ was used to record each sensor’s data, which
were individually sampled at 250 Hz. Five trials of continuous stimulation using a 9 Hz
flashing white light was administered to one subject for 20 seconds durations. For preprocessing a 1st order Butterworth bandpass filter was applied between 2 and 20 Hz. The
SNR was calculated by dividing the amplitude of the visual evoked potential component
at peak latency by the noise power [172].
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Figure 10. EEG electrode SSVEP results. SSVEP triggered at 9 Hz showed improved SNR from
regular case dry to the standard wet.

As shown in Figure 10, the EEG activity shows a peak at the 9 Hz stimulation frequency
from the visual evoked potential. This peak was of similar magnitude compared with the
baseline noise for both standard wet and faraday dry electrodes. The similar SNR values
for the SSVEP task using both electrode types show the potential of the proposed dry EEG
electrode for recordings in BCI applications. However, to ensure its feasibility for regular
EEG recordings, further evaluation works are needed as proposed by Lopez-Gordo [173].
Future works should evaluate other paradigm features in addition to SSVEP. Lastly,
usability features should be tested to guarantee comfort and applicability in different head
types.
The developed wearable EEG system culminated in a device small enough to be
comfortably worn close to the electrode locations. The small size is important because a
light and small device can be positioned closer to the head, allowing for short cabling and
thus reducing motion artefacts. The simple design allows for set up on the subject’s head
in 5-10 minutes. This is crucial for its use with persons with neural disorders, as the
cognitive impairments associated with disease progression make extended recordings and
long setup times, unfeasible.
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3.4.4

Wearable Ground Reaction Force Sensor

Figure 11. Wearable gait analysis system. (Left) Wireless GRF sensor. (Right) GRF sensor and
accompanying insole with 3 piezoresistive transducers.

For gait analysis, a miniaturized system was developed to be comfortably worn at
the ankle, Figure 11. The system is capable of wireless connectivity by use of the CC3200
module. Onboard data storage is also available by employing a micro-SD flashcard. For
motion tracking, the MPU-9250 was also used. GRF is measured using Tekscan’s A301
piezoresistive transducers. The pressure signal is then amplified using an MCP6004 OpAmp. Each system is comprised of two wireless units that clip on the user’s shoe and two
insoles with three embedded piezo transducers. This device has been used in leg-length
discrepancy detection, active prosthetic tuning, and gait phase segmentation for start-stop
prediction based on EEG features [59], [102], [158]. A sample waveform for the kinetic
sensors during bipedal locomotion is shown in Figure 12.

Figure 12. Kinematic gait phases from the wearable ground reaction force sensor.
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3.4.5

Wearable Symptom Measurement

Figure 13. Wearable movement assessment device with internet connectivity. This device is
composed of one inertial measurement unit, located at the distal part of the index finger and a flex
sensor located at the purlicue.

For objective dyskinesia and bradykinesia capture, an upper limb symptom
measurement system will be used, Figure 13. The system is capable of wireless
connectivity by the usage of a CC3200 module. Onboard data storage is also available
through a micro-SD flashcard. For motion tracking, an externally mounted MPU-9250 was
used. The hand opening and closing are measured using a spectral symbol SEN-08606 flex
sensor. Having an objective assessment of disease prognosis will support treatment
modification for accurate and timely intervention. Although several studies have
successfully explored the feasibility of motor symptom measurements, the common
clinical practice still relies upon a subjective assessment performed every 3-6 months,
which encompasses finger tapping, pronation and supination, hand opening and closing,
and the evaluation of resting, and postural tremors.
3.4.5.1

Preliminary Symptom Measurement Testing

This device was tested as a clinic companion to objectively quantify the movement
assessments associated with Parkinson’s Disease. Fifteen persons with Parkinson’s Disease
performed the finger tapping test described in the Movement Disorder Society-Sponsored
48

Unified Parkinson's Disease Rating Scale (MDS-UPDRS). While an experienced Specialist
in Movement Disorders (SMD) rated each finger tapping test, the device shown in Figure
13 recorded kinematic data from a sensor located at the distal part of the index finger and
kinematic features from a flex sensor located at the purlicue. Bradykinesia was calculated
as the decrease in opposition of index flexion amplitude from consecutive iterations, as
well as, the slowness and irregularity of finger tapping. From these metrics, statistical
moments including mean, variance, skewness, and kurtosis, were extracted then min-max
normalization was applied to each feature. Fisher’s linear discriminant analysis was then
computed to lower the dimensional space and ensure separability. A total of thirty
movement assessments were performed on fifteen subjects. Based on this dataset, various
machine learning algorithms were trained to predict the PD stage as rated by the MDS.
Table 2 shows preliminary findings which resulted in prediction accuracy of 95%,
indicating the potential for a standalone device capable of providing real-time objective
symptom assessments.
Table 2 Predicted score consensus with SMD rating

SMD’s MDS-UPDRS Rating
Zero

One

Two

True positive detection

2

4

13

False positive detection

0

1 (Labeled as two)

0

Stage count

2

5

13

Table 1 Consensus between the SMD’s inspection and the algorithm-based classification.
Stages Zero and Two were correctly labeled for 100% of the samples, while stage One had an 80%
true positive detection and a 20% false-positive detection on stage two due to its larger training
size. Other models also yield similarly well-performing classifiers ranging from 80% combined
accuracy for the fine k-nearest neighbors, 85% for the linear support vector machine, 90% for fine
and medium trees, and 95% for quadratic support vector machine.
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3.5
This

Ultra-Wearable Suite Pilot Recording
ecosystem

has

been

developed and tested to achieve
the necessary high-quality EEG
recordings

and

co-registration

with other suite devices while
performing

active

gait.

As

Figure 14. Motion artefact correction. From top to
bottom, this figure shows the steps taken to clean the raw
EEG data from motion corrupting artefacts.

mentioned before, one of the major issues with non-invasive neural explorations is the
problems of synchronicity and noise from artefacts. This study aimed to test the proposed
ultra-wearable suit, which encompassed multisensory data acquisition of scalp electrodes
for EEG, skin surface electrodes for EMG, and ground reaction sensors for gait phase
segmentation. One subject was asked to perform 5 gait cycles from a standstill at a selfselected pace, starting and stopping were also self-timed. A total of 171 events were
recorded, from which 155 epochs were extracted. Sixteen EEG channels were recorded and
sampled at 250 Hz, at electrode locations: F3, Fc3, F4, Fc4, FCz, C1, C3, C5, C2, C4, C6,
CP3, CP4, CPz, Cz, and Pz. Epochs were considered as the time 4 seconds before and 2
seconds after gait initiation as marked by the EMG onset for a sensor located at the tibialis
anterior (TA), the baseline was selected to be between 4 and 2 seconds before gait
initiation. Data were processed using the eeglab toolbox by Delorme & Makeig on
MATLAB [174]. Where it was bandpass filtered between 0.05 – 10 Hz. Then, sinusoidal
artefacts were estimated and removed using the CleanLine function. Afterward, artefact
subspace reconstruction (ASR) was applied to remove flatline channels, low-frequency
drifts, noisy channels, short-time bursts, and incompletely repaired segments from the data.
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At this point, the recording was re-referenced to the common average. Independent
component analysis (ICA), which is a decomposition of input data using the logistic
information, was then applied, Figure 14. From start-stop event averaging and the methods
mentioned above, noise from active gait was attenuated allowing for non-invasive active
gait movement-related cortical potential recordings. Because of the similar frequency
response of the MRCP features relative to the baseline signal, the SNR was measured using
the methods suggested by Karimi et al. expressed in decibels dB.
∑𝐿

∑𝑇 [𝑥𝑆𝑙 (𝑡)]2

𝑆𝑁𝑅 = ∑𝐿𝑙=1 ∑𝑇𝑡=0
𝑙=1

𝑙
2
𝑡=0[𝑥𝑁 (𝑡)]

Eq. 1

where the lth epoch 𝑥𝑆𝑙 (𝑡) and 𝑥𝑁𝑙 (𝑡) are the signal and noise epochs, respectively taken
from [-4, -2] and [-1, 1] s relative to the onset with T samples and L total epochs [175].
Using previously reported SNR values for MRCP, we set a threshold for success to be
above 5.56 dB, as measured using a gold standard Ag/AgCl wet electrode [159].

3.6

Results

The results from this pilot showed the feasibility of the in-house developed sensor
solution for detecting neural patterns during active gait. Figure 15 shows the signature
MRCP neural patterns before gait initiation. The potential shift in the cortical activity
preceding voluntary movements was co-registered to muscle activity to detect the stimulusresponse. Proving the successful implementation of the biopotentials from the scalp,
muscles, and upper and lower limb features. The custom sensor solution could be set-up in
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Figure 15. MRCP pilot results. Cortical activity is known to start prior to actual movement. As
can be seen, the expected polarization 1-2 s before movement is shown, followed by the
depolarization slightly before limb movement, lasting about 500 ms.

under 30 minutes, this includes the EEG, EMG, GRF, and symptom tracking devices.
Crucial for the exploration of active gait neural exploration in cognitively impaired groups,
whose progression makes extended recordings and set-up times unfeasible.
Figure 15 shows the cortical activity, averaged over 155 trials. The clear polarizations
before gait initiation show the sensitivity required to extract the biomarkers under the
proposed paradigm. The early BP is associated with the activation at the pre-SMA, SMA,
and Boardman area. The late BP is associated with activation of the PMC and is indicative
of differences between PD and healthy controls during upper limb finger tapping studies.
The signal-to-noise ratio was 8.54± 4.33 dB indicating the dry electrode and 16 channel
EEG DAQ provide comparable signal quality for MRCP exploration to that of a gold
standard Ag/AgCl wet electrode setup.
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3.7

Discussion

This study resulted in the development of a wearable suite capable of capturing neural
patterns during active gait paradigms. Although there are plenty of commercially available
devices that can deliver gold-standard-level individual sensors recordings[156], [176], our
system allows for co-registration of all sensors within the suite from EEG at the top of the
head to GRF at the plant of the feet, as well as objective symptom tracking. Our sensors’
design focused on providing comparable signal quality to that of gold standards. In the case
of EEG, our device was designed to meet the recommended impedance range during set
up and throughout the recording. Additionally, the developed device showed comparable
SNR [166], [170] and relevant bandwidth [159] responses to that of gold standard devices.
This study also led to the development and validation of a novel device capable of
quantifying the PD stage using an objective measure of bradykinesia. Whereas current
practice still relies on a clinical measure that relies on the experience of an SMD [177],
several groups have aimed at staging PD using objective measures. These measures range
from a camera-based system that resulted in a PD stage classification of 88% [178], to an
inertial measurement unit to record kinematics that resulted in a 90% accuracy [179], and
a microphone to record voice signatures that resulted in a UPDRS prediction accuracy of
96.2%. In addition to a high UPDRS predicted accuracy of 95%, our symptom tracking
device also allows for real-time behavioral tracking with internet connectivity and the
ability to co-register to electrophysiological measures from EEG and EMG and kinematic
and kinetic measures from GRF and the inertial measurement units located on each device
within the suite. Although sensors within the suite were tested and their potential use
verified individually. Because PwP suffer from cognitive decline, it is not feasible to extend
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setup times or recordings due to physical and mental strain. Thus, further work should
focus on employing the complete sensor suite on a cognitively impaired group of PwP to
test longevity and comfort [173].

54

CHAPTER 4 NEURAL BIOMARKERS OF FREEZING OF GAIT IN
PARKINSON’S DISEASE PATIENTS

4.1

Introduction

Persons with PD demonstrate gait impairments that usually increase with disease
progression. It is well understood that PD is characterized by dopaminergic loss, leading
to decreased executive function causing motor symptoms such as tremors, bradykinesia,
dyskinesia, and FoG as well as non-motor symptoms such as loss of smell. However, PwP
often lists FoG as one of the most debilitating symptoms. There have been five nonexclusive mechanism postulations that aim to explain the possible PD physiological
alterations leading to FoG. This study will focus on exploring the second hypothesis, which
states that FoG is caused by a problem with the central drive and automaticity of movement.
It has been proposed that FoG may be due to the loss of automatic updating of motor
programs by the dysfunctional basal ganglia in PD [54], [180]. Characterized by the
inability to perform dual tasks[8], [68]. Previous studies propose that the excitatory drive
from the STN, which projects to the cerebellar cortex, leads to inhibition of the deep
cerebellar nuclei, resulting in the inability to perform previously known tasks[8], [69]. This
problem with the automaticity of movement has also been suggested to be caused by the
cross-talk of the basal ganglia inputs from the motor, cognitive, and limbic cortical areas,
which regularly complement each other in unaffected persons [8]. This model suggests that
there is synchronous activation from the basal ganglia, which inhibits gait control from
brainstem regions. This model is further supported by Gilat et al. who reasons that with
early PD, the frontal-parietal cortices are unaffected, allowing for gait to be controlled by
goal-directed strategies. Whereas in later stages, as gait control becomes less automated,
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cross-talk between these competing regions leads to worsening gait executing while dual
tasking[68].
To further understand this theory, clear biomarkers associated with gait and the
physiological response from muscular activity in preparation to and during active gait are
needed. These markers will help to better understand FoG which in turn may lead to
targeted intervention for improved symptom treatment.

4.2

Related Works

In terms of neural activity, several previous studies have focused on PD to study the
effects of self-paced upper limb activities while recording EEG activity[50], [99], [106]–
[109], [111]. It has been shown that a negative potential, which appears 1-2 s before the
limb movement, is sensed at the central EEG electrodes. This potential is referred to as the
BP and is divided into early and late BP. Early BP occurs 1-2 s before limb movement, this
is associated with activation at the pre-SMA, SMA, and Bordmann area 6 [109]. The late
BP occurs between 400-500 ms before limb movement and is associated with activation of
the primary motor cortex [110]. Studies have shown that early BP can be used as a marker
for motor preparation and is reduced in PwP when compared to healthy controls [108],
[111], [181]. Whereas late BP is overactivated and is theorized to be due to the
compensation mechanisms to achieve limb control in the absence of information handover
from the basal ganglia to the SMA [108]. These results have been largely reproduced only
in PwP while performing upper limb tasks [109]. In terms of the lower limbs, previous
studies have focused on the difference between PwP and healthy controls [113], or in
finding relations between stride length changes and MRCP in PwP with and without FoG
[114].
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In addition to the MRCPs, time-frequency analysis is another method for evaluating
neural patterns. A frequency-specific power increase or decrease in neural activity is
known as an ERS and ERD, respectively [118]. In nominal function, beta synchronization
following movement onset antagonizes movement and help re-establish a postural set
[182]. Whereas desynchronization is related to the preparation of motor responses and
motor selection [128]. In movement disorders and stroke patients, it has been shown that
when patients are required to perform previously learned tasks, available resources for
goal-driven tasks are lessened, leading to inaccurate production of movement, this is
especially salient when multitasking (Frequency-specific biomarkers in neurodegenerative
disorders: Implications of alpha and beta oscillations in motor behavior). In a PD-FoG
study that aimed to find differences in EEG oscillations during a choice-reaction task, beta
and alpha bands showed a reduction in preparatory ERD and delayed ERS, found after
movement onset [183]. Tard et al. found a decrease in beta ERD during upper limb freezing
in PD, this finding suggests that beta oscillations are involved in active immobilization and
the pathogenesis of bradykinesia [128]. Attenuated alpha and low-beta ERD is a marker of
impaired motor preparation in PD [184], which has been suggested to be caused by the
reduction in BG involvement or due to the hypersynchronized thalamocortical activity
[111], [129].
This study built on these previous studies for protocol design, data processing, and
behavioral metric reporting, its main aims are to 1. To explore noninvasive cortical
biomarkers associated with the decoupling of BG-SMA that causes SM-PMC disruptions
in PD patients with FoG. 2. To validate the use of the advanced signal processing
algorithms and sensor fusion for ensuring related cortical potentials are rid of stationary
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and non-stationary artefacts during active gait. 3. To investigate time-frequency and eventrelated alterations in PD patients with and without FoG during active gait.

4.3

Materials and Methods

Patients were recruited from the Movement Disorder Institute at the Sheba Medical
Center. Each patient was approached by their Neurologist who explained the inclusion and
exclusion criteria. Healthy controls were recruited by research collaborators and confirmed
for inclusion in the study [115], [185].
4.3.1

Participants and Experimental Design

As this is an exploratory study; there is not enough data to establish a valid power
analysis. Following similar studies delving into cortical potentials for PD [107], [109],
[112], [114], [186], two experimental groups were investigated in this study; 10 PD patients
with FoG, and 5 age-matched HC (Healthy Controls), for a total of 15 subjects, whose
demographics are shown in Table 3. Each PD participant was instructed to arrive on the
day of the recording during the OFF dopaminergic state, after at least 12 hours of
medication withdrawal. Inclusion criteria included PD participants over 50 years of age
who had been diagnosed with idiopathic PD, who were able to walk 100 m OFF
dopaminergic medication without assistance. Exclusion criteria included significant
comorbidities, recent surgeries, or orthopedic impediments. HCs were included if over 50
years of age, able to walk without assistance, and had no neurological disease that could
affect their gait.
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Table 3.
Subject demographics (mean ± standard deviation).
PD

HC

p-value a

Gender (male/female)

12/3

3/5

0.042

Age

67.7 ± 8.0

63 ± 8.5

0.099

Montreal Cognitive Assessment

22.4 ± 4.0

25.8 ± 2.3

0.029

UPDRS

17.8 ± 7.0

N/A

N/A

Disease Duration

10.5 ± 7.0

N/A

N/A

PD: Parkinson's Disease; HC: Healthy Controls; UPDRS: Unified Parkinson's Disease Rating
Scale.
a

Mann-Whitney U test, except for Chi-Square for gender.

4.3.2

Data Acquisition

Each participant performed three gait-related tasks: (1) standing still for one minute, (2)
walking in a straight line, and (3) turning. Participants wore a portable EEG system
(MicroMED®, Mogliano-Veneto, Italy), sampled at 2048 Hz, which employed a 32
channel EEG montage consisting of Fz, Cz, Pz, Oz, Fp1, Fp2, F7, F8, F3, F4, FT9, FT10,
FC5, FC6, T3, T4, C3, C4, CP5, CP6, TP9, TP10, T5, T6, P3, P4, O1, O2, PO9, and PO10
referenced at C7 and grounded on the left mastoid process. For gait cueing, surface EMG
activity was recorded from four channels sampled at 2048 Hz, located at the Tibialis
Anterior and Gastrocnemius muscles of each leg. In addition to these objective measures,
non-senor-based metrics in the form of clinical scales were also recorded. These include
the United Parkinson's disease rating scale and the Montreal Cognitive Assessment. This
study protocol was approved by the Institutional Review Board of the Sheba Medical

59

Center and the data was recorded in the Center of Advanced Technologies in Rehabilitation
of the medical center [185].
To compare the neural activities of each group, ERD/S were evaluated. ERD is the
decrease in spectral power before movement 0.5-2 s before movement onset [102].
Because ERD is a measure of power change associated with movement intention, a
baseline correction is required. This baseline is commonly recorded during a stationary
period preceding the movement onset and subtracted from the epoch of activity of interest,
which includes the period before and after movement onset. Because the features
associated with ERD/S are frequency band-specific, the Morlet transform was used to
detect the time-locked activity [187], [188].
4.3.3

Signal Processing

4.3.3.1 Processing for ERD/S
Raw EEG data was input into eeglab [174] for processing where a high-pass filter at 0.1
Hz was applied for. This was followed by CleanLine, which removes sinusoidal from ICA
computed components or scalp channels using multi-tapering and a Thompson F-statistics.
Then artefact subspace reconstruction was used to remove flatline channels, low-frequency
drifts, noisy channels, short-time bursts, and incompletely repaired segments from the data.
Following re-referencing to average, ICA was used to estimate cortical potential sources,
then visual inspection was used to remove artefacts in frequency bands or source locations
regarded as noise artefacts. To estimate the power spectrum a Morlet Wavelet was
employed. This wavelet used 0.25 cycles at the lowest frequency which increased linearly
to 1.56 at the highest frequency with a window of 17 samples (66.41 ms). After the power
spectrum was computed. A baseline from two seconds before to one second before gait
initiation was selected as a period of no activity. Each subjects’ baseline was subtracted
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from their own trial and relevant frequency bins were separated for analysis. The relevant
frequency bins were alpha at 8, 10, and 12 Hz and beta starting at 14 Hz and going up to
30 Hz by increments of 2 Hz.
4.3.3.2 Processing for MRCP
Like when processing ERD/S, raw EEG data was input into eeglab then a bandpass filter
was applied between 0.05 to 10 Hz. This was followed by CleanLine, then artefact
subspace reconstruction and re-referencing to average. Then ICA labels were applied and
noisy components or trails were removed. A baseline from two seconds before to one
second before gait initiation was selected as a period of no activity. Each subjects’ baseline
was subtracted from their trials.
4.3.4

Statistical Analysis

Following baseline removal and frequency binning for ERD/S, each subjects’ trials
were averaged to result in a single event for each subject, resulting in 5 samples for the
HC. Because of the unbalanced sample sizes between the HC and the PDFoG group, 5
random subjects within the total PDFoG group were chosen for comparison against the HC
group. An Independent t-test was employed to test the null hypothesis that sets of features
from the PDFoG and HC, came from the same group. A p-value of less than 0.05 would
indicate that the sets of features did not come from the same population, showing statistical
proof of difference.
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4.4

Results

Figure 16. Time-frequency comparison. Each time-frequency decomposition plot is made
up of the average activity for each group. The x-axis represents the time 1500 ms before and
1500 ms after movement onset. The y-axis represents each frequency bin. Blue spots represent
ERD and red spots represent ERS. The rightmost plot represents the intertrial coherence, with
red representing periods of significance between group trials. The PDFoG group shows
significantly less alpha and low beta desynchronization about 290 ms after the start of normal
walking, compared with HC, at the motor cortex. The statistical analysis supports this finding
with the p<0.05 for the comparison of frequency bins starting at 6 Hz and going to 12 Hz, 171
ms after the start of normal walking.

As shown in Figure 16, ERD/S results showed a relative decrease of both alpha and low
beta activity in the PDFoG group compared with the HC. This relative decrease was
observed on C3, CP6, and Cz, both before and after the start of normal walking. The
following will present the channel-by-channel distribution of significant frequency bins
that showed the difference between the subject groups. Channel C3, located near the motor
cortex indicated significantly lower ERD in the alpha and low beta frequency bands after
the start of normal walking, as illustrated in Figure 17. No other time of frequency bands
showed significance when comparing the activity between the PDFoG and HC groups.
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Figure 17. At C3, the PDFoG group shows significantly less alpha and low beta
desynchronization about 290 ms after the start of normal walking, compared with HC.

The boxplot of the ERDs at CP6, 679 ms before the start of normal walking are presented
in Figure 18. At the start of the normal walking event, channel CP6, located in the right
hemisphere near the sensorimotor and parietal cortex also showed significant differences
between the HC and PDFoG group with p<0.05.
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Figure 18. At CP6, the PDFoG group shows significantly less alpha desynchronization 680 ms
and 290 ms before the start of normal walking, compared with HC.

The Cz ERD 679 ms before and 290 ms after the start of normal walking are shown on the
boxplots presented in Figure 19. Consistently with channels C3 and CP6, channel Cz,
which is sensitive to the transition from normal walking to FoG events, also showed
significant differences between the HC and PDFoG groups with p<0.05.
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Figure 19. At Cz, the PDFoG group shows significantly less alpha desynchronization 680 ms
before and 290 ms after the start of normal walking, compared with HC.

Following the observation that not all PDFoG exhibited FoG episodes during at least
one gait task. The PDFoG group was split further into FoG+ and FoG-, the former included
five patients who exhibited FoG events at least during one of the gait-related tasks and the
latter included five patients who did not exhibit FoG events during any of the gait-related
tasks but who had been previously diagnosed as having FoG symptoms. Applying this
segmentation allowed for the exploration of differences between FoG+ and FoG- groups
in both the time-frequency and movement-related features. Conducting t-tests analysis
between HC, FoG-, and FoG+ resulted in significance when comparing the 26 Hz activity
band on channel CP5 about 1 s after the end of normal walking with p<0.05 within pairs
of groups, Figure 20.
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Figure 20. ERD differences between HC, FoG- and FoG+. Both FoG+ and FoG- groups show
significantly less beta desynchronization about 1 s after the stop of normal walking, compared
with HC. Additionally, at 26 Hz there is a significant difference between the FoG+ and FoGgroups.

In addition to the frequency domain evaluation (ERD/S) of the brain’s preparation for
movement execution, time-domain features (MRCP) were also explored. The post-hoc
separation between PDFoG groups into FoG- and FoG+ was also explored for MRCP. A
total of 31±2 trials were averaged across groups. The averaging between C3 and Cz, which
constitute sensory and motor area respectively, showed an initial slope of motor potential
(isMP) and the frontal peak of motor potential (fpMP) differences between the three
groups. The isMP has been shown to originate over the primary motor cortex and represents
activation. The fpMP originates from the supplementary motor area and has been shown
to represent feedback up to 50 ms after movement onset. In PD, the isMP can be expected
to be attenuated and the fpMP is delayed compared with HC [189]. The amplitudes of the
MRCPs for each group are shown in Figure 21. The BP1, which occurs as far back as 2
seconds before movement onset could be ascertained due to the lack of baseline prior to
the movement onset.
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Figure 21. Movement-related cortical potentials. (Top) Averaged MRCP between 5 subjects
for each group. Both FoG+ and FoG- groups show significantly less isMP and fpMP in
preparation and during the execution of normal walking, compared with HC. (Bottom)
Additionally, fpMP is reduced in the FoG+ compared with the FoG- group.

For the Movement related cortical potential results. The analysis was limited to only
analyzing the late BP. This limitation arose from the inability to ensure a period of
inactivity 2 s before the movement onset. Instead, this analysis focused on the late BP or
isMP, which indicates activation of the PMC. HC showed a clear polarization of late BP
about 500 ms prior to the movement onset at a rate of 8.84 μV/s, this is was attenuated in
both FoG- at 2.63μV/s and FoG+ at 1.07 μV/s. After onset, fpMP and peak negativity were
also attenuated in both FoG- at 0.92 μV 132 ms after onset and FoG+ at 0.42 μV 56 ms
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after onset compared with HC at 2.81 μV 80ms after onset, with the largest attenuation
seen for FoG+.

4.5

Discussion

The purpose of this study was to test whether the proposed processing methods would
be powerful enough to confirm the presence of neural patterns during active gait, which
are affected in PDFoG during upper limb paradigms. Previous studies propose that the
excitatory drive from the STN, which projects to the cerebellar cortex, leads to inhibition
of the deep cerebellar nuclei, resulting in the inability to perform previously known tasks
[8], [69]. The problem with the automaticity of movement has also been suggested to be
caused by the crosstalk of the basal ganglia inputs from the motor, cognitive, and limbic
cortical areas, which regularly complement each other in unaffected persons [8]. This
model suggests that there is synchronous activation from the basal ganglia, which in term
inhibits gait control from brainstem regions. Considering that the cortical activity over the
SMA is reduced in PD before self-initiated movement because of the lack of innervation
from the BG. In PD, the preparatory desynchronization (before movement initiation) is
attenuated followed by reduced synchronization after movement execution, compared with
HC. The results from this study support the lack of ERD in PDFoG before and after the
start of normal walking. This lack of ERD may be caused by the affected movement
programming [190], which is associated with reduced activity in the SMA [191]. Similarly,
in PDFoG the ERS onset, before movement initiation, may be affected by earlier,
elongated, increased in magnitude due to lack of ERD compared with HC.
As a feature of ERD/S explorations through EEG, the power change associated with a
specific frequency band is measured relative to the power of a baseline period preceding
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the onset. In the literature, this period is commonly recommended to be recorded several
seconds before the onset occurs. Additionally, because of the time required to develop and
recover slow alpha rhythms, 10 s between task onsets is recommended [187]. Although
this study had originally planned to include the periods of baseline and rest between trials,
due to the pandemic, the originally proposed paradigms, which also aimed to explore the
effects of dopaminergic medication on neural features, were not obtained. Instead, the
dataset in this part of the study was obtained from our collaborators [115], [185]. With this
dataset, the processing pipeline developed to attenuate motion artefacts from an active gait
paradigm was tested. Although the short baseline may negatively affect the quality of the
extracted neural patterns (by resulting in a suboptimal correction to the period of
inactivity), the success of this trial shows the effectiveness of the proposed pipeline in
confirming the presence of relevant neural patterns.
In terms of MRCP, previous studies have investigated movement-related cortical
activity from noninvasive, scalp EEG recordings in PD patients[50], [99], [106]–[108],
[111], mostly while undergoing self-paced upper limb motion. These studies have shown
that the early BP can be used as a biomarker for motor preparation and is reduced in PD
patients when compared to healthy controls when performing upper limb movements[108],
[181], [192]. While the early BP is attenuated, these studies have shown that the late BP is
overactivated and is considered as the compensation mechanism to achieve limb control in
the absence of information handover from the basal ganglia to the SMA in PD
patients[108]. To date, these results have been largely reproduced only in PD patients while
performing upper limb tasks[109] due largely to potential motion artefacts associated with
actual gait. In terms of lower limbs, previous studies have focused on the difference
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between PD patients and healthy controls[113], or in finding relations between stride length
changes and MRCPs in PD patients with and without FoG[52]. In this active gait study,
MRCP features show a decrease in the late BP slope of FoG+ compared to FoG- and HC.
Such a reduction in slope has been matched with a reduction in stride length reduction [52],
which has also been shown to indicated FoG events [193]. The reduced late BP amplitude
may also indicate less neuronal signal projection from BG to the SMA, which may lead to
reduced gait readiness, caudally leading to FoG or difficulty in self-initiated movement.
Although others have reported higher late BP due to the compensatory mechanisms
employed by PwP to execute motor control [108]. This study found a decreased late BP
magnitude in the PD group, which was lowest for the FoG+ who exhibited FoG events at
one or more of the gait tasks. This could be caused by the difference in the tasks
administered, as this study explored changes during active gait, not index finger flexion.
The additional cognitive load associated with gait execution, which in normal function is
cued by the SLN network, becomes disrupted as a result of inhibition of the GPi/SNr
pathway. This pathway breakdown causes engagement of the hyperdirect pathway between
the SMA and STN resulting in affected cerebellar automatic gait processing.

4.6

Conclusions

The purpose of this study was to explore noninvasive cortical biomarkers associated
with the decoupling of basal BG-SMA that causes the SMA-PMC disruptions. Considering
that the cortical activity over the SMA is reduced before self-initiated movement because
of lack of innervation from BG, this study hypothesized that the cortical activity over SMA
associated with motor readiness would be different in PD patients with FoG events
compared with HC. The major technical challenge in the proposed study was to obtain an
70

accurate measurement of cognitive patterns associated with active gait, under the fact that
the cortical recording may be largely distorted by gait-induced motion artefacts. This study
found relative decreases of both alpha and beta activity in the PDFoG group compared with
the HC. These relative differences were observed on C3, CP6, and Cz, in several time
periods both before and after the start of normal walking. Following the observation that
half of the PDFoG group did not exhibit FoG events at any point during the gait tasks,
FoG- and FoG+ subgroups were segmented from the PDFoG group. Statistical analysis
showed significant differences in CP5 between FoG-, FoG+, and HC after the stop of
normal walking. In terms of MRCP activity, the late BP segment showed a reduction in the
FoG+ group compared to both the FoG- and HC groups.
Because of its large heterogeneity, PD is difficult to diagnose and manage. Furthermore,
future works are needed in the exploration of neural biomarkers that differentiate PD
subtypes during active gait paradigms. If better care strategies are to be developed, which
take into consideration the case by case differences between PwP, a better understanding
of how brain pathways are affected during gait with dopaminergic loss is required. This
study provided support for the exploration of noninvasive biomarkers that may provide
accurate assessments of pathophysiology in PD subgroups; this may lead to targeted
intervention and improved symptom treatment for PD patients with FoG[54], [194]. Also,
the technical innovations focused on dealing with the motion artefacts that have
discouraged previous groups from performing active gait neural exploration. The results
from this study support the feasibility of active gait MRCP research. Non-invasive
biomarker research that relies on smart denoising algorithms for noise cancelation, and
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the implementation of ultra-wearable suites for the investigation of other diseases and in
other fields.
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